Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

CUSIP: 00887A204

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
26,288,053
Total 13F shares
1,356,571
Share change
+1,356,571
Total reported value
$3,214,622
Price per share
$2.37
Number of holders
16
Value change
+$3,214,622
Number of buys
16

Quarterly Holders Quick Answers

What is CUSIP 00887A204?
CUSIP 00887A204 identifies RNTX - Rein Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX) as of Q4 2022

As of 31 Dec 2022, Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,356,571 shares. The largest 10 holders included Alerce Investment Management, L.P., BVF INC/IL, VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, GEODE CAPITAL MANAGEMENT, LLC, KCK LTD., RENAISSANCE TECHNOLOGIES LLC, ADVISOR GROUP HOLDINGS, INC., UBS Group AG, and Tower Research Capital LLC (TRC). This page lists 16 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.